Filing Details
- Accession Number:
- 0001437749-13-015949
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-12 18:05:52
- Reporting Period:
- 2013-03-14
- Filing Date:
- 2013-12-12
- Accepted Time:
- 2013-12-12 18:05:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
806888 | Response Biomedical Corp | RBM | Services-Testing Laboratories (8734) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
939362 | F Anthony Holler | 1781 - 75Th Avenue W. Vancouver A1 V6P 6P2 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-11-28 | 45,500 | $1.05 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2012-04-02 | 20,000 | $0.00 | 20,000 | $2.20 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2013-03-14 | 20,000 | $0.00 | 20,000 | $3.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,000 | 2022-04-02 | No | 4 | A | Direct | |
40,000 | 2023-03-14 | No | 4 | A | Direct |
Footnotes
- Exercise prices shown are denominated in Canadian dollars.
- 100% of the options vest on the one year anniversary of the date of grant.
- On June 19, 2012, the final voting results of the annual meeting of the Company's shareholders effected a consolidation of the Company's outstanding common shares such that each twenty outstanding common shares will be consolidated into one common share.